abstract |
THE INVENTION REFERS TO PHARMACEUTICAL COMPOSITIONS FOR ORAL APPLICATION, WHICH CONTAIN IBANDRONAT AND ARE WELL TOLERATED, OR A PHYSIOLOGICALLY TOLERATED SALT OF THE SAME, IN THE FORM OF ACTIVE INGREDIENT. THE METHOD OF ADMINISTRATION CONSISTS OF AN INTERIOR SECTION CONTAINING THE ACTIVE INGREDIENT AND IS SURROUNDED BY A COATING, FREE OF ACTIVE INGREDIENT, SO THAT THE ACTIVE INGREDIENT IS RELEASED QUICKLY. |